Selected article for: "ifn induction and type ifn induction"

Author: Hermesh, Tamar; Moltedo, Bruno; López, Carolina B.; Moran, Thomas M.
Title: Buying Time—The Immune System Determinants of the Incubation Period to Respiratory Viruses
  • Document date: 2010_11_18
  • ID: 0yqv2osb_32
    Snippet: TLR agonists are potent inducers of cytokine production. It is, therefore, surprising that very little evidence exists for inhibition of the TLR signaling pathway by the viruses discussed above. It has been suggested that certain RSV strains and MeV can inhibit type I IFN induction by TLR-7 and TLR-9 signaling. In the case of MeV, the V protein acts as a decoy substrate for the kinase IκB kinase α, competing with IRF7 [79] [80] [81] . No eviden.....
    Document: TLR agonists are potent inducers of cytokine production. It is, therefore, surprising that very little evidence exists for inhibition of the TLR signaling pathway by the viruses discussed above. It has been suggested that certain RSV strains and MeV can inhibit type I IFN induction by TLR-7 and TLR-9 signaling. In the case of MeV, the V protein acts as a decoy substrate for the kinase IκB kinase α, competing with IRF7 [79] [80] [81] . No evidence exists for such inhibition by Influenza, HRV or human parainfluenza virus (hPIV) (Figure 1 ).

    Search related documents:
    Co phrase search for related documents
    • cytokine production and human parainfluenza virus: 1
    • cytokine production and ifn induction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cytokine production and little evidence: 1, 2
    • cytokine production and pathway signal: 1, 2, 3, 4
    • cytokine production and RSV strain: 1
    • cytokine production and TLR agonist: 1, 2, 3
    • discuss virus and hPIV human parainfluenza virus: 1
    • discuss virus and human parainfluenza virus: 1, 2
    • hPIV human parainfluenza virus and human parainfluenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • human parainfluenza virus and ifn induction: 1
    • ifn induction and pathway signal: 1, 2, 3, 4, 5
    • ifn induction and potent inducer: 1, 2, 3, 4, 5, 6
    • ifn induction and signal ifn induction: 1
    • ifn induction and TLR inhibition: 1
    • pathway signal and TLR agonist: 1
    • potent inducer and TLR agonist: 1